ResearcherZhongda Hospital Southeast UniversityActive in the last 2 years

Peng Ping Xie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6175-9422; OpenAlex author ID A5085205645. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper

Papers 1

Transcriptome data-based status of PI3K/AKT/mTOR pathway indicates heterogeneity and immune modulation in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jgm.3570 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Siyuan Tan · 1 shared paper, 2024 · strength 0.28
- Paper Transcriptome data-based status of PI3K/AKT/mTOR pathway indicates heterogeneity and immune modulation in patients with… DOI 10.1002/jgm.3570 ↗
Haifeng Li · 1 shared paper, 2024 · strength 0.28
- Paper Transcriptome data-based status of PI3K/AKT/mTOR pathway indicates heterogeneity and immune modulation in patients with… DOI 10.1002/jgm.3570 ↗
Jiahua Zhou · 1 shared paper, 2024 · strength 0.28
- Paper Transcriptome data-based status of PI3K/AKT/mTOR pathway indicates heterogeneity and immune modulation in patients with… DOI 10.1002/jgm.3570 ↗
Haodong Tang · 1 shared paper, 2024 · strength 0.28
- Paper Transcriptome data-based status of PI3K/AKT/mTOR pathway indicates heterogeneity and immune modulation in patients with… DOI 10.1002/jgm.3570 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.